Advertise your medicines

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) provides comprehensive guidance for pharmaceutical companies regarding the promotion of medicines in the UK. Operating under the regulatory framework of the 'Blue Guide' and UK Advertising Codes, this document applies to all entities marketing medicinal products. As a general guidance document, it does not detail specific company inspections or dates, but rather establishes universal standards. Main violations identified include advertising prescription-only medicines (POMs) to the public, making misleading claims about safety or effectiveness, and targeting children. Required actions for advertisers include mandatory inclusion of active ingredients and dosage instructions for public ads, and detailed scientific data for professional promotions. Traditional herbal and homeopathic products must also avoid claims of clinical proven effectiveness. Failure to comply can result in the MHRA requiring the immediate withdrawal or amendment of advertisements, mandatory pre-vetting of future materials, and public corrections. In severe cases, breaches of these regulations are criminal offenses punishable by fines or up to two years of imprisonment. Oversight is managed in collaboration with the Advertising Standards Authority (ASA) and the Prescription Medicines Code of Practice Authority (PMCPA) to ensure public safety and transparency.